Usefulness of intravenous magnesium for multifocal atrial tachycardia in patients with chronic obstructive pulmonary disease

American Journal of Cardiology

Volumn 81, Issue 1, 1998, Pages 91-93

  McCord, James K ^a   Borzak, Steven ^b   Davis, Thomas ^b   Gheorghiade, Mihai ^b  

^a HENRY FORD HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; DIGOXIN; DILTIAZEM; MAGNESIUM; THEOPHYLLINE; VERAPAMIL;

ADULT; AGED; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; ELECTROCARDIOGRAM; ELECTROLYTE DISTURBANCE; FEMALE; HEART RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT INDICATION;

AGED; AGED, 80 AND OVER; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIA; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; LUNG DISEASES, OBSTRUCTIVE; MAGNESIUM; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; TACHYCARDIA; TIME FACTORS;

EID: 0031963936     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00809-6     Document Type: Article

References (18)

1. 1. Shine KI, Kastor JA, Yurchak PM. Multifocal atrial tachycardia: clinical and electrocardiographic features in 32 patients. N Engl J Med 1968;279: 344-349.
2. 2. Lipson MJ, Naimi S. Multifocal atrial tachycardia: clinical associations and significance. Circulation 1970;42:397-407.
3. 3. Kones RJ, Phillips JH, Hersh J. Mechanism and management of chaotic atrial mechanism. Cardiology 1974;59:92-101.
4. 4. Scher DL, Arsura EL. Multifocal atrial tachycardia: mechanisms, clinical correlates and treatment. Am Heart J 1989;118:574-580.
5. 5. Wang K, Goldfarb BL, Gobel FL, Richman HG. Multifocal atrial tachycardia: a clinical analysis in 41 cases. Arch Intern Med 1977;137:161-164.
6. 6. Arsura EL, Lefkin AS, Scher DL, Solar M, Tessler S. A randomized double-blind placebo controlled study of verapamil or metoprolol in multifocal atrial tachycardia. Am J Med 1988;85:519-524.
7. 7. Hazard PB, Burnett CR. Treatment of multifocal atrial tachycardia with metoprolol. Crit Care Med 1987;15:20-25.
8. 8. Arsura EL, Salor M, Lefkin AS, Scher DL, Tessler S. Metoprolol in the treatment of multifocal atrial tachycardia. Crit Care Med 1987;15:591-594.
9. 9. Hazard PB, Burnett CR. Verapamil in multifocal atrial tachycardia: hemodynamic and respiratory changes. Chest 1987;91:68-70.
10. 10. Levine JH, Michael JR, Guarnieri T. Treatment of multifocal atrial tachycardia with verapamil. N Engl J Med 1985;312:21-25.
11. 11. Aronow WS, Plasencia G, Wong R. Effect of verapamil versus placebo on PAT and MAT (paroxysmal atrial tachycardia and multifocal atrial tachycardia). Curr Ther Res 1980;27:823-829.
12. 12. Salerno DM, Anderson B, Sharkey PJ, Iber C. Intravenous verapamil for treatment of multifocal atrial tachycardia with and without calcium pretreatment. Ann Intern Med 1987;107:623-628.
13. 13. Kouvarus G, Cokkinis DV, Halal G. The effective treatment of multifocal atrial tachycardia with amiodarone. Jpn Heart J 1989;30:301-312.
14. 14. Suger PT, Widershorn J, Petersen R. Prospective evaluation of parenteral magnesium sulfate in the treatment of patients with reentrant AV supraventricular tachycardia. Am Heart J 1990;119:308-316.
15. 15. Wesley RC, Haines DE, Lerman BB, DiMarco JP, Crampton RS. Effect of intravenous magnesium sulfate on supraventricular tachycardia. Am J Cardiol 1989;63:1129-1131.
16. 16. Gullestad L, Birheland K, Molstad P, Hoyer MM, Vanberg P, Kjekshus J. The effect of magnesium versus verapamil on supraventricular arrhythmias. Clin Cardiol 1993;16:429-434.
17. 17. Iseri LT, Fairshter RD, Hardeman JL, Brodsky MA. Magnesium and potassium therapy in multifocal atrial tachycardia. Am Heart J 1985;110:789-794.
18. 18. Cohen L, Kitzes R, Shnaider H. Multifocal atrial tachycardia responsive to parenteral magnesium. Magnes Res 1988;1:239-242.